These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27589969)

  • 1. Quantitative Information on Oncology Prescription Drug Websites.
    Sullivan HW; Aikin KJ; Squiers LB
    J Cancer Educ; 2018 Apr; 33(2):371-374. PubMed ID: 27589969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consumer confusion between prescription drug precautions and side effects.
    Amoozegar JB; Rupert DJ; Sullivan HW; O'Donoghue AC
    Patient Educ Couns; 2017 Jun; 100(6):1111-1119. PubMed ID: 28069321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct-to-Consumer Promotion of Prescription Drugs on Mobile Devices: Content Analysis.
    Aikin KJ; Sullivan HW; Dolina S; Lynch M; Squiers LB
    J Med Internet Res; 2017 Jul; 19(7):e225. PubMed ID: 28676469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites.
    Sullivan HW; O'Donoghue AC; Rupert DJ; Willoughby JF; Aikin KJ
    J Health Commun; 2017 Feb; 22(2):171-181. PubMed ID: 28129069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testimonials and Informational Videos on Branded Prescription Drug Websites: Experimental Study to Assess Influence on Consumer Knowledge and Perceptions.
    Sullivan HW; O'Donoghue AC; Gard Read J; Amoozegar JB; Aikin KJ; Rupert DJ
    J Med Internet Res; 2018 Jan; 20(1):e13. PubMed ID: 29362205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actors in whitespace: Communicating risk information on pharmaceutical websites.
    O'Donoghue AC; Sullivan HW; Rupert DJ; Fitts Willoughby J; Aikin KJ
    Health Mark Q; 2019; 36(2):152-167. PubMed ID: 30907290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements.
    Sullivan HW; O'Donoghue AC; Lynch M; Johnson M; Davis C; Rupert DJ
    Med Decis Making; 2019 Nov; 39(8):975-985. PubMed ID: 31583947
    [No Abstract]   [Full Text] [Related]  

  • 8. Disclosing accelerated approval on direct-to-consumer prescription drug websites.
    Sullivan HW; O'Donoghue AC; David KT; Patel NJ
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1277-1280. PubMed ID: 30264874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual presentations of efficacy data in direct-to-consumer prescription drug print and television advertisements: A randomized study.
    Sullivan HW; O'Donoghue AC; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ
    Patient Educ Couns; 2016 May; 99(5):790-9. PubMed ID: 26749356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asking a doctor versus referring to the Internet: A comparison study on consumers' reactions to DTC (direct-to-consumer) prescription drug advertising.
    Jiang P
    Health Mark Q; 2018; 35(3):209-226. PubMed ID: 30551729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease Information in Direct-to-Consumer Prescription Drug Print Ads.
    Aikin KJ; Sullivan HW; Betts KR
    J Health Commun; 2016; 21(2):228-39. PubMed ID: 26717304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electronic direct-to-consumer advertising of pharmaceuticals: an assessment of textual and visual content of websites.
    Alkazemi MF; Van Stee SK
    Health Educ Res; 2020 Apr; 35(2):134-151. PubMed ID: 32144424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical Test of the Beneficial Consequences of Lifting the Ban on Direct-to-Consumer Advertising for Prescription Drugs in Italy: Experimental Exposure and Questionnaire Study.
    Schulz PJ; Crosignani F; Petrocchi S
    J Med Internet Res; 2023 Jul; 25():e40616. PubMed ID: 37459159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How is cervical cancer screening information communicated in UK websites? Cross-sectional analysis of content and quantitative presentation formats.
    Okan Y; Smith SG; Bruine de Bruin W
    BMJ Open; 2019 Oct; 9(10):e029551. PubMed ID: 31662361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis.
    Adams C
    J Med Internet Res; 2016 Feb; 18(2):e33. PubMed ID: 26892749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do Prescription Drug Ads Tell Consumers Enough About Benefits and Side Effects? Results From the Health Information National Trends Survey, Fourth Administration.
    Sullivan HW; Campbell M
    J Health Commun; 2015; 20(12):1391-6. PubMed ID: 26120940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can online consumers contribute to drug knowledge? A mixed-methods comparison of consumer-generated and professionally controlled psychotropic medication information on the internet.
    Hughes S; Cohen D
    J Med Internet Res; 2011 Jul; 13(3):e53. PubMed ID: 21807607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Narratives to Deliver Information in Direct-To-Consumer Prescription Drug Commercials: A Content Analysis.
    Ball JG; Applequist J
    J Health Commun; 2019; 24(5):512-524. PubMed ID: 31256712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical Marketing in the United States, 1997-2016.
    Schwartz LM; Woloshin S
    JAMA; 2019 Jan; 321(1):80-96. PubMed ID: 30620375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship Between Exposure to Direct-To-Consumer Prescription Drug Advertising (DTCA) and Patients' Belief Accessibility and Medication Adherence.
    Im H; Huh J
    Health Commun; 2019 Aug; 34(9):975-983. PubMed ID: 29521524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.